Mechanisms of disease: Breast tumor pathogenesis and the role of the myoepithelial cell

Nature Clinical Practice Oncology

Volumn 3, Issue 3, 2006, Pages 138-151

  Barsky, Sanford H ^a   Karlin, Nina J ^b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OLIVE VIEW UCLA MEDICAL CENTER   (United States)

Author keywords

Angiogenic inhibitors; Breast microenvironment; Expression profile; Myoepithelial cells; Proteinase inhibitors

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOGENIC FACTOR; ESTRADIOL; GENE PRODUCT; MASPIN; PROTEINASE; PROTEINASE INHIBITOR; SCLEROPROTEIN; TAMOXIFEN;

BASAL CELL; BIOTECHNOLOGY; BREAST CANCER; BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST EPITHELIUM; CANCER INHIBITION; CANCER INVASION; CANCER PREVENTION; CARCINOMA IN SITU; CELL FUNCTION; CELL IMMORTALIZATION; CELL MANIPULATION; CELL SELECTION; CELL TRANSFORMATION; CELL ULTRASTRUCTURE; CULTURE MEDIUM; DISEASE MARKER; DRUG MECHANISM; FUNCTIONAL ANATOMY; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; INHIBITION KINETICS; INTRADUCTAL CARCINOMA; METASTASIS INHIBITION; MOLECULAR BIOLOGY; MYOEPITHELIUM CELL; NONHUMAN; PARACRINE SIGNALING; PHENOTYPE; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; STROMA CELL; TUMOR VASCULARIZATION; TUMOR XENOGRAFT;

ANGIOGENESIS INHIBITORS; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; HUMANS; MUSCLE CELLS; PROTEASE INHIBITORS;

EID: 33645339525     PISSN: 17434254     EISSN: 17434262     Source Type: Journal    
DOI: 10.1038/ncponc0450     Document Type: Review

References (52)

1. Liu HL et al. (2005) Proliferation and polarity in breast cancer: untying the gordian knot. Cell Cycle 4: 646-649
2. Kim JB et al. (2005) Tumour-stromal interactions in breast cancer: The role of stroma in tumourigenesis. Tumour Biol 26: 173-185
3. Rizki A and Bissell MJ (2004) Homeostasis in the breast: In takes a village. Cancer Cell 6: 1-2
4. Allinen M et al. (2004) Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6: 17-32
5. Hu M et al. (2005) Distinct epigenetic changes in the stromal cells of breast cancers. Nat Genetics 37: 899-905
6. Sternlicht MD et al. (1996) Establishment and characterization of a novel human myoepithelial cell line and matrix-producing xenograft from a parotid basal cell adenocarcinoma. In Vitro Cell Dev Biol 32: 550-563
7. Lakhani SR and O'Hare MJ (2000) The mammary myoepithelial cell - Cinderella or ugly sister? Breast Cancer Res 3: 1-4
8. Jones C et al. (2004) Expression profiling of purified normal human luminal and myoepithelial breast cells: Identification of novel prognostic markers for breast cancer. Cancer Res 64: 3037-3045
9. Gudjonsson T et al. (2002) Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. J Cell Science 115: 39-50
10. Nguyen M et al. (2000) The human myoepithelial cell displays a multifaceted anti-angiogenic phenotype. Oncogene 19: 3449-3459
11. Alford D and Taylor-Papadimitriou J (1996) Cell adhesion molecules in the normal and cancerous mammary gland. J Mammary Gland Biol Neoplasia 1: 207-218
12. Adriance MC et al. (2005) Myoepithelial cells: Good fences make good neighbors. Breast Cancer Res 7: 190-197
13. Gudjonsson T et al. (2003) To create the correct microenvironment: three-dimensional heterotypic collagen assays for human breast epithelial morphogenesis and neoplasia. Methods 30: 247-255
14. Jolicoeur F et al. (2003) Basal cells of second trimester fetal breasts: immunohistochemical study of myoepithelial precursors. Pediatr and Dev Path 6: 398-413
15. Deugnier MA et al. (2002) The importance of being a myoepithelial cell. Breast Cancer Res 4: 224-230
16. Fridriksdottir AJR et al. (2005) Maintenance of cell type diversification in the human breast. J Mammary Gland Biol Neoplasia 10: 61-74
17. Sternlicht M et al. (1996) Characterizations of the extracellular matrix and proteinase inhibitor content of human myoepithelial tumors. Lab Invest 74: 781-796
18. Sternlicht M and Barsky SH (1997) The myoepithelial defense: A host defense against cancer. Med Hypotheses 48: 37-46
19. Sternlicht MD et al. (1997) The human myoepithelial cell is a natural tumor suppressor. Clin Cancer Res 3: 1949-1958
20. Bissell MJ and Labarge MA (2005) Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment? Cancer Cell 7: 17-23
21. Xiao G et al. (1999) Suppression of breast cancer growth and metastasis by a serpin myoepithelium-derived serine proteinase inhibitor expressed in the mammary myoepithelial cells. Proc Natl Acad Sci USA 96: 3700-3705
22. Jones JL et al. (2003) Primary breast myoepithelial cells exert an invasion-suppressor effect on breast cancer cells via paracrine down-regulation of MMP expression in fibroblasts and tumour cells. J Pathol 201: 562-572
23. Jolicoeur F et al. (2002) Multifocal, nascent, and invasive myoepithelial carcinoma (malignant myoepithelioma) of the breast: An immunohistochemical and ultrastructural study. Int J Surg Pathol 10: 281-291
24. Jones C et al. (2001) CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation. Br J Cancer 85: 422-427
25. Scarpellini F et al. (1997) Malignant myoepithelioma associated with in situ and invasive ductal carcinoma: Description of a case and review of the literature. Pathologica 89: 420-424
26. Foschini MP and Eusebi V (1998) Carcinomas of the breast showing myoepithelial cell differentiation. Virchows Arch 432: 303-310
27. Jones C et al. (2000) Comparative genomic hybridization analysis of myoepithelial carcinoma of the breast. Lab Invest 80: 831-836
28. Teuliere J et al. (2005) Targeted activation of β-catenin signaling in basal mammary epithelial cells affects mammary development and leads to hyperplasia. Development 132: 267-277
29. Cardiff RD et al. (2000) The mammary pathology of genetically engineered mice: The consensus report and recommendations from the Annapolis meeting. Oncogene 19: 966-967
30. Cavenee WK (1993) A siren song from tumor cells. J Clin Invest 91: 3
31. Safarians S et al. (1996) The primary tumor is the primary source of metastasis in a human melanoma/SCID model: Implications for the direct autocrine and paracrine epigenetic regulation of the metastatic process. Int J Cancer 66: 151-158
32. Liotta LA et al. (1991) Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 64: 327-336
33. Folkman J and Klagsbrun M (1987) Angiogenic factors. Science 235: 442-447
34. Cornil I et al. (1991) Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression. Proc Natl Acad Sci USA 88: 6028-6032
35. Sgroi DC et al. (1999) In vivo gene expression profile analysis of human breast cancer progression. Cancer Res 59: 5656-5661
36. Barsky SH (2003) Myoepithelial mRNA expression profiling reveals a common tumor-suppressor phenotype. Exp Mol Path 74: 113-122
37. Guelstein VI et al. (1993) Myoepithelial and basement membrane antigens in benign and malignant human breast tumors. Int J Cancer 53: 269-277
38. Cutler LS (1990) The role of extracellular matrix in the morphogenesis and differentiation of salivary glands. Adv Dent Res 4: 27-33
39. Gudjonsson T et al. (2004) Immortalization protocols used in cell culture models of human breast morphogenesis. Cell Mol Life Sci 61: 2523-2534
40. Liu S et al. (2005) Mammary stem cells, self-renewal pathways and carcinogenesis. Breast Cancer Res 7: 86-95
41. Dontu G and Wicha MS (2005) Survival of mammary stem cells in suspension culture: Implications for stem cell biology and neoplasia. J Mammary Gland Biol Neoplasia 10: 75-86
42. Dontu G et al. (2003) In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 17: 1253-1270
43. Gudjonsson T et al. (2002) Isolation, immortalization and characterization of a human breast epithelial cell line with stem cell properties. Genes Dev 16: 693-706
44. Pechoux P et al. (1999) Human mammary luminal epithelial cells contain progenitors to myoepithelial cells. Dev Biol 206: 88-89
45. Petersen OW et al. (2003) Epithelial progenitor cell lines as models of normal breast morphogenesis and neoplasia. Cell Prolif 36 (Suppl 1): S33-S44
46. Kedeshian P et al. (1998) Humatrix, a novel myoepithelial matrical gel with unique biochemical and biological properties. Cancer Lett 123: 215-226
47. Zhang M et al. (2000) Maspin is an angiogenesis inhibitor. Nat Med 6: 196-199
48. Nguyen M et al. (2000) The human myoepithelial cell displays a multifaceted anti-angiogenic phenotype. Oncogene 19: 3449-3459
49. Shao ZM et al. (2000) Tamoxifen enhances myoepithelial cell suppression of human breast carcinoma progression by two different effector mechanisms. Cancer Lett 157: 133-144
50. Love SM and Barsky SH (1996) Breast-duct endoscopy to study stages of cancerous breast disease. Lancet 348: 997-999
51. Perou CM et al. (2000) Molecular portraits of human breast tumors. Nature 406: 747-752
52. Sorlie T et al. (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98: 10869-10874